Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.
Overview
and 18 other authors
Daehee Hwang13, Do Young Hyeon13, Sunghyun Huh13, Hyung Joon Kwon1, Seokjun Ha1, Sanha Park1, Hyeji Shin1, Jeong Taik Kwon14, Heon Yoo15, Ho-Shin Gwak15, Michael D Taylor16,17,18,19,20,21,22,23,24,25, Bong Jin Park26, Jason K Sa27,28, Youngwook Kim1, Antonio Iavarone5,29, Sung-Hye Park10,30, Seung-Ki Kim6,9, Jong Bae Park1,3131 affiliations
- Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi Republic of Korea
- Proteomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang, Gyeonggi Republic of Korea
- Department of Applied Chemistry, School of Science and Technology, Kookmin University, Seoul, Republic of Korea
- Neurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu, Republic of Korea
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL USA
- Division of Pediatric Neurosurgery, Pediatric Clinical Neuroscience Center, Seoul National University Children’s Hospital, Seoul, Republic of Korea
- Department of Medical Science Convergence, Graduate School of Medical Science, University of Ulsan, Ulsan, Korea
- Department of Pharmacy, School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea
- Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
- Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
- Department of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea
- AIMEDBIO, Songpa-gu, Seoul, Republic of Korea
- School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
- Department of Neurosurgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea
- Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea
- The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario Canada
- Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario Canada
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario Canada
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada
- Texas Children’s Cancer and Hematology Center, Houston, TX USA
- Department of Pediatrics — Hematology/Oncology, Baylor College of Medicine, Houston, TX USA
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX USA
- Department of Neurosurgery, Texas Children’s Hospital, Houston, TX USA
- Department of Surgery, University of Toronto, Toronto, Ontario Canada
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX USA
- Department of Neurosurgery, Kyung Hee University College of Medicine, Seoul, Republic of Korea
- Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Republic of Korea
- Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea
- Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL USA
- Neuroscience Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
- Center for Multi-omics, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea
Abstract
Current treatment strategies for medulloblastoma remain ineffective owing to extensive tumor heterogeneity. We generated five platforms of omics data including liquid chromatography and mass spectrometry-based proteome and performed integrated multi-omic characterization to improve the conventional molecular classification of medulloblastoma. We identified seven refined distinct subtypes. The sonic hedgehog (SHH) group was reclassified into two subgroups, SHHα and SHHβ, whereas group 4 was divided into three subgroups, G4α, G4β, and G4γ. SHH and group 4 subtypes exhibit two distinct neuronal differentiation trajectories: granular neuron and unipolar brush cell differentiation (SHHβ and G4γ, respectively), both of which associated with more favorable clinical outcomes. Furthermore, we uncovered unique proteomic and kinomic properties that conferred increased treatment vulnerabilities to targeted therapeutic interventions against each of the three medulloblastoma subtypes associated with poor clinical outcomes. We demonstrated the therapeutic potential of exploiting these vulnerabilities by utilizing a proteasome inhibitor and subtype-specific agents, including CDK1/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE85217, at NCBI GEO; found in the text, “Proteogenomic analyses unveil targets and…”
Other data links
- ncbi.nlm.nih.gov/
sra , NCBI; found in “Data availability”
Data availability
Raw omics data have been deposited in public repositories. Proteomic data have been deposited in the Proteomic Data Commons (PDC, https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 38 authors, 4 keywords, 10 MeSH terms, 2 funders, 21 references.
Cite
This paper
Park, S.-M., Kim, K.-H., Yoon, J. H., D’Angelo, F., Choi, S. A., Kim, C. I., Koo, H., Park, S., Kim, H., Sundara Raj, S., Kim, S. S., Park, A. K., Koh, E. J., Kim, S.-I., Shim, Y.-M., Kwang-Hoon, L., Kim, E. E., Phi, J. H., Jo, Y. S., . . . Park, J. B. (2026). Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression. Experimental & molecular medicine, 58(6), 1885-1899. https://
BibTeX
@article{park2026compreh
author = {Park, Seong-Min and Kim, Kyung-Hee and Yoon, Jong Hyuk and D’Angelo, Fulvio and Choi, Seung Ah and Kim, Chan Il and Koo, Harim and Park, Seungmin and Kim, Hyondeog and Sundara Raj, Sreeja and Kim, Sung Soo and Park, Ae Kyung and Koh, Eun Jung and Kim, Seong-Ik and Shim, Yu-Mi and Kwang-Hoon, Lee and Kim, Eric Eunshik and Phi, Ji Hoon and Jo, Yeon Suk and Nam, Do Hyun and Hwang, Daehee and Hyeon, Do Young and Huh, Sunghyun and Kwon, Hyung Joon and Ha, Seokjun and Park, Sanha and Shin, Hyeji and Kwon, Jeong Taik and Yoo, Heon and Gwak, Ho-Shin and D Taylor, Michael and Park, Bong Jin and Sa, Jason K and Kim, Youngwook and Iavarone, Antonio and Park, Sung-Hye and Kim, Seung-Ki and Park, Jong Bae},
title = {{Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression}},
journal = {Experimental \& molecular medicine},
year = {2026},
month = jun,
volume = {58},
number = {6},
pages = {1885--1899},
publisher = {Korean Society for Biochemistry and Molecular Biology},
issn = {1226-3613},
doi = {10.1038/
url = {https://
pmid = {42249086},
pmcid = {PMC13323399}
}
RIS
TY - JOUR
AU - Park, Seong-Min
AU - Kim, Kyung-Hee
AU - Yoon, Jong Hyuk
AU - D’Angelo, Fulvio
AU - Choi, Seung Ah
AU - Kim, Chan Il
AU - Koo, Harim
AU - Park, Seungmin
AU - Kim, Hyondeog
AU - Sundara Raj, Sreeja
AU - Kim, Sung Soo
AU - Park, Ae Kyung
AU - Koh, Eun Jung
AU - Kim, Seong-Ik
AU - Shim, Yu-Mi
AU - Kwang-Hoon, Lee
AU - Kim, Eric Eunshik
AU - Phi, Ji Hoon
AU - Jo, Yeon Suk
AU - Nam, Do Hyun
AU - Hwang, Daehee
AU - Hyeon, Do Young
AU - Huh, Sunghyun
AU - Kwon, Hyung Joon
AU - Ha, Seokjun
AU - Park, Sanha
AU - Shin, Hyeji
AU - Kwon, Jeong Taik
AU - Yoo, Heon
AU - Gwak, Ho-Shin
AU - D Taylor, Michael
AU - Park, Bong Jin
AU - Sa, Jason K
AU - Kim, Youngwook
AU - Iavarone, Antonio
AU - Park, Sung-Hye
AU - Kim, Seung-Ki
AU - Park, Jong Bae
TI - Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression
T2 - Experimental & molecular medicine
J2 - Exp Mol Med
PY - 2026
DA - 2026/
VL - 58
IS - 6
SP - 1885
EP - 1899
SN - 1226-3613
PB - Korean Society for Biochemistry and Molecular Biology
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression",
"container-title": "Experimental & molecular medicine",
"author": [
{
"family": "Park",
"given": "Seong-Min"
},
{
"family": "Kim",
"given": "Kyung-Hee"
},
{
"family": "Yoon",
"given": "Jong Hyuk"
},
{
"family": "D’Angelo",
"given": "Fulvio"
},
{
"family": "Choi",
"given": "Seung Ah"
},
{
"family": "Kim",
"given": "Chan Il"
},
{
"family": "Koo",
"given": "Harim"
},
{
"family": "Park",
"given": "Seungmin"
},
{
"family": "Kim",
"given": "Hyondeog"
},
{
"family": "Sundara Raj",
"given": "Sreeja"
},
{
"family": "Kim",
"given": "Sung Soo"
},
{
"family": "Park",
"given": "Ae Kyung"
},
{
"family": "Koh",
"given": "Eun Jung"
},
{
"family": "Kim",
"given": "Seong-Ik"
},
{
"family": "Shim",
"given": "Yu-Mi"
},
{
"family": "Kwang-Hoon",
"given": "Lee"
},
{
"family": "Kim",
"given": "Eric Eunshik"
},
{
"family": "Phi",
"given": "Ji Hoon"
},
{
"family": "Jo",
"given": "Yeon Suk"
},
{
"family": "Nam",
"given": "Do Hyun"
},
{
"family": "Hwang",
"given": "Daehee"
},
{
"family": "Hyeon",
"given": "Do Young"
},
{
"family": "Huh",
"given": "Sunghyun"
},
{
"family": "Kwon",
"given": "Hyung Joon"
},
{
"family": "Ha",
"given": "Seokjun"
},
{
"family": "Park",
"given": "Sanha"
},
{
"family": "Shin",
"given": "Hyeji"
},
{
"family": "Kwon",
"given": "Jeong Taik"
},
{
"family": "Yoo",
"given": "Heon"
},
{
"family": "Gwak",
"given": "Ho-Shin"
},
{
"family": "D Taylor",
"given": "Michael"
},
{
"family": "Park",
"given": "Bong Jin"
},
{
"family": "Sa",
"given": "Jason K"
},
{
"family": "Kim",
"given": "Youngwook"
},
{
"family": "Iavarone",
"given": "Antonio"
},
{
"family": "Park",
"given": "Sung-Hye"
},
{
"family": "Kim",
"given": "Seung-Ki"
},
{
"family": "Park",
"given": "Jong Bae"
}
],
"container-title-short":
"volume": "58",
"issue": "6",
"page": "1885-1899",
"DOI": "10.1038/
"PMID": "42249086",
"PMCID": "PMC13323399",
"ISSN": "1226-3613",
"publisher": "Korean Society for Biochemistry and Molecular Biology",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
5
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.7150/ijbs.116040
- Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models.Journal: International journal of biological sciencesIn common: NCBI GEO GSE85217, genetics / omics, other condition, 4 references
- [2] doi:10.1038/s41586-026-10612-6 [code]
- Acquired genetic and cell-state changes in IDH-mutant glioma progression.Journal: NatureIn common: other condition, cellular / molecular, 2 authors
- [3] doi:10.1172/jci196753 [code]
- Protein phosphatase 2A regulates senescence and immunogenicity in medulloblastoma models.Journal: The Journal of clinical investigationIn common: NCBI GEO GSE85217, other condition, cellular / molecular, 2 references
- [4] doi:10.3390/cells15050474
- Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.Journal: CellsIn common: genetics / omics, other condition, 4 references
- [5] doi:10.1111/bpa.70092
- Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/
accessible diagnostic methods. Journal: Brain pathology (Zurich, Switzerland)In common: genetics / omics, other condition, 4 references - [6] doi:10.1093/neuonc/noag053
- ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.Journal: Neuro-oncologyIn common: NCBI GEO GSE85217, other condition
- [7] doi:10.1038/s41467-026-76161-8
- The m⁶A reader YTHDF2 regulates mRNA transport and axon outgrowth in developing neurons.Journal: Nature communicationsIn common: author Jong Hyuk Yoon
- [8] doi:10.1007/s12017-026-08935-8
- Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.Journal: Neuromolecular medicineIn common: genetics / omics, other condition, cellular / molecular, 2 references
- [9] doi:10.1113/jp289326
- Maternal obesity induces activator protein 1-mediated inflammatory response to impair embryonic neurogenesis.Journal: The Journal of physiologyIn common: genetics / omics, other condition, 1 reference
- [10] doi:10.1016/j.clinsp.2026.101003
- Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis.Journal: Clinics (Sao Paulo, Brazil)In common: genetics / omics, other condition, cellular / molecular, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
